Literature DB >> 28182850

Conjugate Vaccines from Bacterial Antigens by Squaric Acid Chemistry: A Closer Look.

Peng Xu1, Meagan Kelly2, Willie F Vann3, Firdausi Qadri4, Edward T Ryan2,5,6, Pavol Kováč1.   

Abstract

By using O-SP-core (O-SPcNH2 ) polysaccharide, isolated from Vibrio cholera O1 lipopolysaccharide (LPS) and related synthetic substances, a detailed study of factors that affect conjugation of bacterial polysaccharides to protein carriers through squaric acid chemistry to form conjugate vaccines has been carried out. Several previously unrecognized processes that take place during the squarate labeling of the O-SPcNH2 and subsequent conjugation of the formed squarate (O-SPcNH-SqOMe) have been identified. The efficiency of conjugation at pH 8.5, 9.0, and 9.5 to bovine serum albumin (BSA) and to the recombinant tetanus toxin fragment C (rTT-Hc) has been determined. The study led to a protocol for more efficient labeling of O-SPcNH2 antigen with the methyl squarate group, to yield a higher-quality, more potent squarate conjugation reagent. Its use resulted in about twofold increases in conjugation efficiency (from 23-26 % on BSA to 51 % on BSA and 55 % on rTT-Hc). The spent conjugation reagent could be recovered and regenerated by treatment with MeI in the absence of additional base. The immunological properties of the experimental vaccine made from the regenerated conjugation reagent were comparable with those of the immunogen made from the parent O-SPcNH-SqOMe.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  O-specific polysaccharides; antigens; glycoconjugates; selective methylation; vaccines

Mesh:

Substances:

Year:  2017        PMID: 28182850      PMCID: PMC5664186          DOI: 10.1002/cbic.201600699

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  36 in total

1.  Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV Infection.

Authors:  Louise C Ivers; Richelle C Charles; Isabelle J Hilaire; Leslie M Mayo-Smith; Jessica E Teng; J Gregory Jerome; Jenna Rychert; Regina C LaRocque; Peng Xu; Pavol Kovácˇ; Edward T Ryan; Firdausi Qadri; Charles P Almazor; Molly F Franke; Jason B Harris
Journal:  J Infect Dis       Date:  2015-02-26       Impact factor: 5.226

2.  Synthesis of the tetrasaccharide side chain of the major glycoprotein of the Bacillus anthracis exosporium.

Authors:  Rina Saksena; Roberto Adamo; Pavol Kovác
Journal:  Bioorg Med Chem Lett       Date:  2005-11-04       Impact factor: 2.823

3.  Identification of a binding site for ganglioside on the receptor binding domain of tetanus toxin.

Authors:  Heather A Louch; Ellen S Buczko; Mary A Woody; Richard M Venable; Willie F Vann
Journal:  Biochemistry       Date:  2002-11-19       Impact factor: 3.162

4.  Synthesis of a BSA-Le(x) glycoconjugate and recognition of Le(x) analogues by the anti-Le(x) monoclonal antibody SH1: the identification of a non-cross reactive analogue.

Authors:  Jo-Wen Wang; Ari Asnani; France-Isabelle Auzanneau
Journal:  Bioorg Med Chem       Date:  2010-08-22       Impact factor: 3.641

5.  One-pot preparation of a series of glycoconjugates with predetermined antigen-carrier ratio from oligosaccharides that mimic the O-PS of Vibrio cholerae O:1, serotype Ogawa.

Authors:  Rina Saksena; Xingquan Ma; Pavol Kovác
Journal:  Carbohydr Res       Date:  2003-11-14       Impact factor: 2.104

6.  Action of alpha-chymotrypsin on the diethyl esters of fumaric, maleic, and acetylenedicarboxylic acids.

Authors:  S G Cohen; L H Klee; S Y Weinstein
Journal:  J Am Chem Soc       Date:  1966-11-20       Impact factor: 15.419

Review 7.  Be squared: expanding the horizon of squaric acid-mediated conjugations.

Authors:  Frederik R Wurm; Harm-Anton Klok
Journal:  Chem Soc Rev       Date:  2013-07-22       Impact factor: 54.564

8.  Synthesis, conjugation, and immunological evaluation of the serogroup 6 pneumococcal oligosaccharides.

Authors:  Archana R Parameswar; In Ho Park; Rina Saksena; Pavol Kovác; Moon H Nahm; Alexei V Demchenko
Journal:  Chembiochem       Date:  2009-12-14       Impact factor: 3.164

9.  A new homobifunctional p-nitro phenyl ester coupling reagent for the preparation of neoglycoproteins.

Authors:  Xiangyang Wu; Chang-Chun Ling; David R Bundle
Journal:  Org Lett       Date:  2004-11-25       Impact factor: 6.005

10.  Synthesis and molecular structure of the 5-methoxycarbonylpentyl α-glycoside of the upstream, terminal moiety of the O-specific polysaccharide of Vibrio cholerae O1, serotype Inaba.

Authors:  Peng Xu; Edwin D Stevens; Alfred D French; Pavol Kováč
Journal:  Molecules       Date:  2015-02-11       Impact factor: 4.411

View more
  11 in total

1.  Isolation, Purification, Characterization and Direct Conjugation of the Lipid A-Free Lipopolysaccharide of Vibrio cholerae O139.

Authors:  Peng Xu; Jana Korcová; Peter Baráth; Alžbeta Čížová; Jana Valáriková; Firdausi Qadri; Meagan Kelly; Robert D O'Connor; Edward T Ryan; Slavomír Bystrický; Pavol Kováč
Journal:  Chemistry       Date:  2019-08-20       Impact factor: 5.236

2.  Virus-like Particle Display of Vibrio cholerae O-Specific Polysaccharide as a Potential Vaccine against Cholera.

Authors:  Zahra Rashidijahanabad; Meagan Kelly; Mohammad Kamruzzaman; Firdausi Qadri; Taufiqur R Bhuiyan; Hunter McFall-Boegeman; Di Wu; Grzegorz Piszczek; Peng Xu; Edward T Ryan; Xuefei Huang
Journal:  ACS Infect Dis       Date:  2022-02-16       Impact factor: 5.578

3.  Conjugation of carbohydrates to proteins using di(triethylene glycol monomethyl ether) squaric acid ester revisited.

Authors:  Peng Xu; Michael N Trinh; Pavol Kováč
Journal:  Carbohydr Res       Date:  2017-11-07       Impact factor: 2.104

Review 4.  Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends.

Authors:  Francesca Micoli; Roberto Adamo; Paolo Costantino
Journal:  Molecules       Date:  2018-06-15       Impact factor: 4.411

5.  Enzymatic Synthesis of N-Acetyllactosamine (LacNAc) Type 1 Oligomers and Characterization as Multivalent Galectin Ligands.

Authors:  Thomas Fischöder; Dominic Laaf; Carina Dey; Lothar Elling
Journal:  Molecules       Date:  2017-08-10       Impact factor: 4.411

6.  A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model.

Authors:  Lana Kandalaft; Ananda Mookerjee; Michele Graciotti
Journal:  Bioimpacts       Date:  2018-06-10

7.  Comparative Antigenicity of Thiourea and Adipic Amide Linked Neoglycoconjugates Containing Modified Oligomannose Epitopes for the Carbohydrate-Specific anti-HIV Antibody 2G12.

Authors:  Nino Trattnig; Patrick Mayrhofer; Renate Kunert; Lukas Mach; Ralph Pantophlet; Paul Kosma
Journal:  Bioconjug Chem       Date:  2018-12-28       Impact factor: 4.774

8.  Cholera: Immunity and Prospects in Vaccine Development.

Authors:  Jason B Harris
Journal:  J Infect Dis       Date:  2018-10-15       Impact factor: 5.226

9.  Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults.

Authors:  Brie Falkard; Richelle C Charles; Wilfredo R Matias; Leslie M Mayo-Smith; J Gregory Jerome; Evan S Offord; Peng Xu; Pavol Kováč; Edward T Ryan; Firdausi Qadri; Molly F Franke; Louise C Ivers; Jason B Harris
Journal:  PLoS Negl Trop Dis       Date:  2019-01-31

10.  Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.

Authors:  Mohammad Kamruzzaman; Meagan Kelly; Pavol Kováč; Peng Xu; Edward T Ryan; Richelle C Charles; Jason B Harris; Stephen B Calderwood; Aklima Akter; Rajib Biswas; M Hasanul Kaisar; Taufiqur R Bhuiyan; Louise C Ivers; Ralph Ternier; Jean-Gregory Jerome; Hélene B Pfister; Xiaowei Lu; Sameh E Soliman; Bart Ruttens; Rina Saksena; Jana Mečárová; Alžbeta Čížová; Firdausi Qadri; Slavomír Bystrický
Journal:  mSphere       Date:  2021-07-07       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.